Condition: COVID-19 · SARS-COV-2 Infection · Sponsor: BioNTech SE
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group, LLC | Anniston, Alabama, United States | — |
| North Alabama Research Center | Athens, Alabama, United States | — |
| Simon Williamson Clinic / Synexus Clinical Research US, Inc. | Birmingham, Alabama, United States | — |
| Accel Research Sites - Birmingham Clinical Research Unit | Birmingham, Alabama, United States | — |
| Cullman Clinical Trials | Cullman, Alabama, United States | — |
| AMR Clinical | Daphne, Alabama, United States | — |
| Medical Affiliated Research Center | Huntsville, Alabama, United States | — |
| AMR Clinical | Mobile, Alabama, United States | — |
| Chandler Clinical Trials | Chandler, Arizona, United States | — |
| Scottsdale Clinical Trials | Scottsdale, Arizona, United States | — |
| Epic Medical Research-Sun City | Sun City, Arizona, United States | — |
| Noble Clinical Research | Tucson, Arizona, United States | — |
+ 184 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.